News
Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’. Long-term monitoring of patients to collect outcome data after treatment with these therapies will be...
Neil Rees, Head of Research, OPEN Health Patient & Brand Communication takes 15 minutes to answer some key questions on insights and market research in pharma 1. What sets the research team at OPEN...
Having just returned from a very busy but hugely enjoyable few days at congress, I wanted to share our views on the event and key themes that our healthcare communications practices took away from the discussions and presentations. It was great to see a higher proportion of attendees...
While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the care pathway for a patient, there appear to be inconsistencies within the...
Harnessing the power of collaborations to bring real insights and improve outcomes The imminent explosion of gene and other advanced therapies brings with it a lot of hope and expectation along with...
Rob Pilbrow, Global Managing Director, Medical Writing, OPEN Health takes 15 minutes to answer some key questions on scientific writing 1. What are the key medical and scientific writing activities that pharma is currently investing...
Authors: A M Patel, S L Corman, S Chaplin, K Raimundo, R F Sidonio Jr. Published: Journal of Medical Economics, 2019 View publication Aims Cumulative exogenous factor VIII (FVIII) exposure is an...
Patient engagement (PE) is BIG business, and for the pharmaceutical companies that have invested in its application across the product lifecycle, the rewards are significant. Patient centricity has long been a buzzword...
Sumira Riaz, Health Psychologist at OPEN Health Patient & Brand Communications, takes 15 minutes to answer some key questions on patient-centricity in pharma. 1. Still working in clinical practice, why do you work...